As with SDF-1 beta, there are variant alleles within the coding regions of the chemokine receptors CCR5 and CCR2. As you recall, CCR5 and CCR2 are coreceptors for M-tropic HIV. The variants for CCR5 and CCR2 are CCR5-delta 32 and CCR2-641 respectively. These mutant alleles are dominant and protective. In fact, 25 to 30% of HIV positive survivors who don't contact AIDS for >16 years have one or both of these protective variants instead of the alternate form of the respective coreceptors.

So the question experimenters had was how does SDF1- 3'A/3'A compare in its protective effect to the CCR5 and CCR2 variants? When SDF1- 3'A/3'A is present in concert with one or both of the protective variants for CCR5 and CCR2, is the protective effect on the individual a sum of those provided individualy by the variants?

To answer such questions, the experimenters conducted an analysis of the genotypes of a group of individuals. The survivability values of individuals with different genotypes (combination of protective and non-protective variants for SDF1-beta, CCR5 and CCR2) were compared to each other and plotted against time from seroconversion.

 

Crefully observe the protective effects of each genotype. In each figure, which genotype provides the greatest protection?

or or or


Why is the protective effect of "Pink" genotype greater than that of "Orange" genotype? (hint: compare the two genotypes)

What does this say about the protective effects of more than one variant?


Now compare the protective effects of the "Orange" genotype to the "Green" genotype. Which of the two provides more protection (only consider the graphs reflecting the endpoint as defined by the definition of AIDS from 1987 and death)? or

What do the levels of protection provided by "Orange" (3'A/3'A, +/+ at CCR5/CCR2) and "Green"

(SDF1 +/+, one or more CCR5/CCR2 protective genotypes) suggest?

Congratulations, you have just completed the module!!

 

 

[Back to the main page][Back to Dr. Kandel's homepage]